Gender Outcomes INternational Group: to Further Well-being Development
Topic: Sex, Gender and Health
Background: Beyond biological sex, gender is increasingly recognized as a pivotal determinant of health. However, there is a lack of standardized gender measurement. We hypothesize that gender-related factors and their effect will vary substantially between countries and diseases.
Aims: Our aims are to determine the impact of sex and gender-related factors on health across different chronic diseases, to identify gender-related measurements that are disease and country specific and to construct innovative ways to disseminate the application of gender measurement towards personalized approaches to prevention, diagnosis and treatment
Methods: With a five-country transatlantic network, we will benchmark innovative solutions to measure gender. Gender-related factors, cost-sensitive and patients reported outcomes will be identified and their associations investigated in over 20 accessible cohorts of patients affected by cardiovascular, chronic kidney and cerebrovascular diseases, mental illness and metabolic syndrome. Large database analysis/machine learning approaches will allow the derivation of pan and within country disease specific gender scores which will be validated through e-Health applications in prospective disease groups. Educational modules will be developed to promote awareness.
Innovation: As a five-country multidisciplinary consortium with access to granular large databases, we are uniquely positioned to harness an innovative methodology that will provide a framework to close gender gaps in chronic disease and promote knowledge transfer in clinical practice.
Coordinator: Research Institute of the McGill University Health Centre, Canada, Dr. Louise Pilote
Research Institute of the McGill University Health Centre
Medical University of Vienna
Research Center of the European University of Cyprus
Universidad de Murcia
University of Alberta
University of British-Colombia
University of Toronto